RTTNews | Jun 21, 2021 10:56AM EDT

10:55 Monday, June 21, 2021 (RTTNews.com) - MediciNova, Inc. (MNOV) shares are trading above 17 percent on Monday morning after the company announced positive results from phase 2 trial of MN-166 or ibudilast in alcohol use disorder or AUD.

The study evaluated the effect of 14 days of ibudilast treatment on mood, heavy drinking, and neural reward signals in 52 individuals with alcohol use disorder.

Currently, shares are at $4.42, up 17.55 percent from the previous close of $3.70 on a volume of 16,073,013. The shares have traded in a range of $3.71-$13.25 on a volume of 301,582 for the last 52 weeks.

Read the original article on RTTNews ( https://www.rttnews.com/3203798/stock-alert-medcinova-up-17-on-positive-results-for-mn-166-in-alcohol-use-disorder.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved